<?xml version="1.0" encoding="UTF-8"?>
<p>These recent therapeutic proposals evidence of the continuing natural products playing a role in drug discovery and development [
 <xref rid="B9-biomolecules-10-00817" ref-type="bibr">9</xref>]. A comprehensive review of human drugs introduced since 1981 suggests that, from 847 small molecule-based drugs, 43 were natural products, 232 were derived from natural products (usually semi-synthetic), and 572 were synthetic molecules. However, 262 of the 572 synthetic molecules had a natural product-inspired pharmacophore or could be considered natural product analogues [
 <xref rid="B10-biomolecules-10-00817" ref-type="bibr">10</xref>]. Besides, more than 60% of current anticancer drugs have their origin from natural sources [
 <xref rid="B9-biomolecules-10-00817" ref-type="bibr">9</xref>].
</p>
